Table 1.

Expression of CCR2 and CCL2 by human tumor lines and patient samples.

Type of tumor cell	Cell line	CCR2	CCL2	Reference
Breast carcinoma	MDA-MB-231	+	+/-	(128–130)
	MCF10A	+	-	(131)
	MCF7	+	+	(129)
	4T1	+	+	(128, 129)
	Patient samples	+	+	(132)
Osteosarcoma	MG63	+	+	(133)
	U2OS	+	+	(133)
	HOS	+	+	(133)
	Patient samples	+		(125)
Non-small cell lung carcinoma	A549	+	+	(128, 134)
	NCI-H460	-	+	(134)
	NCI-H1299	+		(128)
	LC99A	-	-	(134)
	Patient samples	+	+	(135)
Hepatocellular carcinoma	Huh-7	+	+	(136, 137)
	HepG2	+	+	(136, 138)
	Hep3B,		+	(136, 138)
	MHCC-97L,		+	(136)
	MHCC-97H	+	+	(136, 138)
	LM3		+	(136)
	SMMC-7721		-	(136, 138)
	Patient samples	+	+	(136, 138)
Oophoroma	OVCAR-3	+		(139)
	SK-OV-3	+	+	(139, 140)
	Patient samples	+		(139)
Gastric adenocarcinoma	SGC7901		+	(141)
	BGC823		+	(141)
	GES-1	Inducible		(141)
	GC1401, GC1415 and GC1436	-		(142)
	Patient samples	+	+	(141, 143)
Prostatic cancer	PC-3	+	+	(28, 128)
	DU145	+		(128)
	LNCap	+		(128)
	C42B	+		(128)
	Patient samples	+		(128)
Pancreatic cancer	Panc-1		+	(144)
	PC13		+	(144)
	PT45P1		+	(144)
	Capan-1		+	(144)
	MiaPaca-2		+	(144)
	Patient samples		+	(145)
Renal carcinoma	786-O	+	+	(146)
	CaKi-1	+	+	(146)
	Patient samples	+	+, CCL7+	(126, 147)
Melanoma/epidermoid carcinoma	LM16-R cells		+	(148, 149)
	A431		+	(150)
	Patient samples		+	(148, 149)
Glioblastoma/meningioma	IOMM Lee		+	(151)
	SF-3061		+	(151)
	Patient samples	+	+	(152, 153)
Colorectal cancer	HCT116	+		(154)
	SW480	+		(154)
	SW1116p21 cells		+	(155)
	Patient samples	+	+	(154–156)
Head and neck cancer	Patient samples	+		(157)
Blood cancer	Kas	+/-		(127, 128)
	Raw264.7	+	+	(43)
	THP-1	+	+	(127)
	NB4	+	+	(158)
	U937	+/-	+	(127, 159)
	Patient samples	+		(127)